Recruiting

Latarjet vs. Modified Eden-Hybinette for Recurrent Anterior Shoulder Dislocation

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study compares the effectiveness of Latarjet and Modified Eden-Hybinette procedures in improving shoulder stability, as measured by the Western Ontario Shoulder Instability Index (WOSI), in individuals with recurrent anterior shoulder dislocation.

What is being tested

Latarjet procedure

+ Modified Eden-Hybinette

Procedure
Who is being recruted

Shoulder Injuries+3

+ Joint Dislocations

+ Joint Diseases

Over 16 Years
+12 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: September 2016
See protocol details

Summary

Principal SponsorUniversity of Sao Paulo
Study ContactMauro EC Gracitelli, PhDMore contacts
Last updated: January 30, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2016

Actual date on which the first participant was enrolled.

This study focuses on finding the best treatment for recurrent anterior dislocation of the shoulder, a condition where the shoulder frequently slips out of its socket. It compares two surgical techniques: Latarjet and Modified Eden-Hybinette. The Latarjet technique has shown reliable results with low recurrence rates, but it comes with potential complications like neurological injuries and graft resorption. On the other hand, the Eden-Hybinette surgery has fewer risks and allows better restoration of the shoulder area, but it lacks the benefits of the 'sling effect' provided by the Latarjet technique. This research aims to address the current lack of high-quality studies comparing these two techniques, hoping to improve care and treatment outcomes for individuals with this condition. During the study, participants will undergo either the Latarjet or the Modified Eden-Hybinette surgery. The effectiveness of these surgeries will be measured using the Western Ontario Shoulder Instability Index (WOSI), a standard tool for assessing shoulder instability. This will help evaluate the success of each technique in reducing shoulder dislocations and improving overall shoulder function.

Official TitleRandomized Trial for the Treatment of Recurrent Anterior Dislocation of the Shoulder: Latarjet Versus Modified Eden-Hybinette
NCT02913352
Principal SponsorUniversity of Sao Paulo
Study ContactMauro EC Gracitelli, PhDMore contacts
Last updated: January 30, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

60 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 16 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Shoulder InjuriesJoint DislocationsJoint DiseasesMusculoskeletal DiseasesShoulder DislocationWounds and Injuries

Criteria

6 inclusion criteria required to participate
History of one or more previous episodes of traumatic glenohumeral dislocation;

Anterior glenoid bone loss superior to 20% of its diameter, regardless of the ISIS score;

Recurrence of glenohumeral dislocation in cases previously treated with arthroscopic Bankart repair, regardless of the ISIS score and severity of bone lesion of the glenoid;

Borderline bipolar bone lesions:

Show More Criteria

6 exclusion criteria prevent from participating
Hill-Sachs lesion greater than 40% of the humeral head diameter (measured by the preoperative CT);

Untreated seizures;

Previously diagnosed rotator cuff complete tear;

Fractures of the proximal humerus (except for Hill-Sachs lesions);

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Open Latarjet-Patte procedure. Surgery. Anterior glenoid bone graft from coracoid. Fixation with 2 screws.

Group II

Experimental
Surgery. Modified Eden-Hybinette surgery, with capsular repair on the iliac bone Anterior glenoid bone graft from iliac bone. Fixation with 2 screws.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Instituto de Ortopedia e Traumatologia

São Paulo, BrazilOpen Instituto de Ortopedia e Traumatologia in Google Maps
Recruiting
One Study Center